e-learning
resources
Munich 2006
Monday 04.09.2006
COPD and inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reliability of cause-specific mortality adjudication in the TORCH clinical trial
L. P. A. McGarvey, M. John, J. A. Anderson, M. T. Zvarich, R. A. Wise (Belfast, Greenford, United Kingdom; Prerow, Germany; RTP, Baltimore, United States Of America)
Source:
Annual Congress 2006 - COPD and inflammation
Session:
COPD and inflammation
Session type:
Oral Presentation
Number:
1999
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. P. A. McGarvey, M. John, J. A. Anderson, M. T. Zvarich, R. A. Wise (Belfast, Greenford, United Kingdom; Prerow, Germany; RTP, Baltimore, United States Of America). Reliability of cause-specific mortality adjudication in the TORCH clinical trial. Eur Respir J 2006; 28: Suppl. 50, 1999
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
A clinical scoring algorithm to predict all cause mortality in COPD
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007
An observational study of risk factors for hospitalization of chronic obstructive pulmonary disease exacerbation and their outcome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study
Source: Eur Respir J 2011; 39: 38-45
Year: 2012
Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study
Source: Eur Respir J 2012; 39: 38-45
Year: 2012
Impact of chronic obstructive pulmonary disease on specific-cause of mortality: a national cohort study
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019
Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): A two-year study
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Mortality in COPD: role of comorbidities
Source: Eur Respir J 2006; 28: 1245-1257
Year: 2006
Comorbid conditions reported in patients with COPD recruited into a global clinical trial (UPLIFT)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
Potential misclassification of causes of death from COPD
Source: Eur Respir J 2006 Oct 01;28(4):781-785
Year: 2006
Long-term follow-up of the ISOLDE participants: causes of death after 13 years of the trial completion
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007
Exacerbations of chronic obstructive pulmonary disease (COPD): Correlation of hospitalization days with epidemiological and clinical parameters
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007
Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Global burden of COPD: systematic review and meta-analysis
Source: Eur Respir J 2006; 28: 523-532
Year: 2006
Misdiagnosed COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007
Assessing the multivariate structure and influence of comorbidity in COPD
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
Prevalence of undiagnosed COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007
The outcome of patients with COPD admitted to UK hospitals with an exacerbation. Results from the RCP/BTS national COPD audit
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept